KLG Stock +78.58% In 3 Months Since We Picked KLG Stock +78.58% In 3 Months Since We Picked Unlock All Top Buy Picks

Range Low Price High Price Comment
30 days $3.25 $5.20 Thursday, 25th Apr 2024 AVXL stock ended at $3.39. This is 0.587% less than the trading day before Wednesday, 24th Apr 2024. During the day the stock fluctuated 6.62% from a day low at $3.25 to a day high of $3.47.
90 days $3.25 $6.90
52 weeks $3.25 $10.31

Historical Anavex Life Sciences Corp. prices

Date Open High Low Close Volume
Nov 30, 2023 $7.27 $7.42 $7.07 $7.21 1 135 782
Nov 29, 2023 $6.88 $7.22 $6.83 $7.09 1 120 391
Nov 28, 2023 $6.53 $6.86 $6.29 $6.78 847 340
Nov 27, 2023 $6.85 $7.00 $6.18 $6.36 2 262 411
Nov 24, 2023 $6.85 $7.25 $6.81 $7.07 672 415
Nov 22, 2023 $6.76 $6.89 $6.54 $6.70 946 713
Nov 21, 2023 $7.00 $7.54 $6.70 $6.72 2 386 401
Nov 20, 2023 $7.00 $7.07 $6.62 $7.00 2 138 715
Nov 17, 2023 $6.09 $6.33 $6.01 $6.27 708 620
Nov 16, 2023 $6.22 $6.22 $5.87 $6.01 741 889
Nov 15, 2023 $6.25 $6.53 $6.18 $6.18 876 488
Nov 14, 2023 $6.04 $6.24 $5.99 $6.22 1 088 574
Nov 13, 2023 $5.63 $5.77 $5.47 $5.75 700 053
Nov 10, 2023 $5.80 $5.83 $5.55 $5.74 708 605
Nov 09, 2023 $5.98 $6.01 $5.65 $5.71 1 206 938
Nov 08, 2023 $6.21 $6.27 $5.87 $5.97 1 127 208
Nov 07, 2023 $5.97 $6.23 $5.88 $6.21 1 330 147
Nov 06, 2023 $6.02 $6.14 $5.84 $5.93 758 306
Nov 03, 2023 $5.71 $6.18 $5.60 $6.04 1 215 651
Nov 02, 2023 $5.62 $5.78 $5.53 $5.69 886 646
Nov 01, 2023 $5.57 $5.69 $5.46 $5.62 618 444
Oct 31, 2023 $5.45 $5.64 $5.32 $5.58 738 247
Oct 30, 2023 $5.19 $5.55 $5.19 $5.50 690 352
Oct 27, 2023 $5.65 $5.78 $5.18 $5.20 1 004 900
Oct 26, 2023 $5.62 $5.91 $5.48 $5.62 1 075 815
Click to get the best stock tips daily for free!

About Anavex Life Sciences Corp.

Anavex Life Sciences . Anavex Life Sciences Corp., a clinical stage biopharmaceutical company, engages in the development of drug candidates for the treatment of central nervous system (CNS) diseases. Its lead drug candidate is ANAVEX 2-73, which is in Phase III clinical trial for the treatment of Alzheimer's disease; Phase III clinical trial to treat pediatric patients with Rett syndrome; Phase II clinical trial for the treatment of Parkinson's disease; and preclinica... AVXL Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT